Accuracy of urine flow cytometry and urine test strip in predicting relevant bacteriuria in different patient populations.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
25 Feb 2021
Historique:
received: 16 01 2020
accepted: 12 02 2021
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 20 3 2021
Statut: epublish

Résumé

Urinary tract infection (UTI) is diagnosed combining urinary symptoms with demonstration of urine culture growth above a given threshold. Our aim was to compare the diagnostic accuracy of Urine Flow Cytometry (UFC) with urine test strip in predicting bacterial growth and in identifying contaminated urine samples, and to derive an algorithm to identify relevant bacterial growth for clinical use. Species identification and colony-forming unit (CFU/ml) quantification from bacterial cultures were matched to corresponding cellular (leucocytes/epithelial cells) and bacteria counts per μl. Results comprise samples analysed between 2013 and 2015 for which urine culture (reference standard) and UFC and urine test strip data (index tests, Sysmex UX-2000) were available. 47,572 urine samples of 26,256 patients were analysed. Bacteria counts used to predict bacterial growth of ≥10 Prediction of a relevant bacterial growth by bacteria counts was most accurate and was a better predictor than leucocyte counts independently of the source of the urine and the medical specialty ordering the test (medical, surgical or others).

Sections du résumé

BACKGROUND BACKGROUND
Urinary tract infection (UTI) is diagnosed combining urinary symptoms with demonstration of urine culture growth above a given threshold. Our aim was to compare the diagnostic accuracy of Urine Flow Cytometry (UFC) with urine test strip in predicting bacterial growth and in identifying contaminated urine samples, and to derive an algorithm to identify relevant bacterial growth for clinical use.
METHODS METHODS
Species identification and colony-forming unit (CFU/ml) quantification from bacterial cultures were matched to corresponding cellular (leucocytes/epithelial cells) and bacteria counts per μl. Results comprise samples analysed between 2013 and 2015 for which urine culture (reference standard) and UFC and urine test strip data (index tests, Sysmex UX-2000) were available.
RESULTS RESULTS
47,572 urine samples of 26,256 patients were analysed. Bacteria counts used to predict bacterial growth of ≥10
CONCLUSIONS CONCLUSIONS
Prediction of a relevant bacterial growth by bacteria counts was most accurate and was a better predictor than leucocyte counts independently of the source of the urine and the medical specialty ordering the test (medical, surgical or others).

Identifiants

pubmed: 33632129
doi: 10.1186/s12879-021-05893-3
pii: 10.1186/s12879-021-05893-3
pmc: PMC7908726
doi:

Substances chimiques

Reagent Strips 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

209

Références

Curr Opin Infect Dis. 2016 Feb;29(1):73-9
pubmed: 26694621
Clin Chim Acta. 2013 Sep 23;424:90-5
pubmed: 23721948
Clin Chim Acta. 2015 Aug 25;448:86-90
pubmed: 26123581
World J Urol. 2013 Jun;31(3):547-51
pubmed: 22588552
J Infect Dis. 1982 May;145(5):667-72
pubmed: 7077091
Clin Infect Dis. 2018 Aug 31;67(6):e1-e94
pubmed: 29955859
Med Decis Making. 2011 May-Jun;31(3):405-11
pubmed: 21191120
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
J Clin Microbiol. 2010 Sep;48(9):3117-21
pubmed: 20592157
World J Urol. 2014 Dec;32(6):1587-94
pubmed: 24452449
BMC Urol. 2004 Jun 02;4:4
pubmed: 15175113
Nephron. 2016;132(3):215-26
pubmed: 26930608
Dis Markers. 2019 Mar 3;2019:5853486
pubmed: 30944667
Acad Emerg Med. 2016 Mar;23(3):323-30
pubmed: 26782662
Int J Microbiol. 2017;2017:8532736
pubmed: 29090008
J Adv Nurs. 2019 Mar;75(3):517-527
pubmed: 30259542

Auteurs

Christian Gehringer (C)

University Hospital Basel, Division of Internal Medicine, University of Basel, Basel, Switzerland.
University Hospital Basel, Division of Clinical Bacteriology and Mycology, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
University Hospital Basel, Department of Clinical Research, University of Basel, Basel, Switzerland.

Axel Regeniter (A)

Current affiliation: Medica Medical Laboratories Dr. F. Käppeli, Wolfbachstrasse 17, Zurich, Switzerland.

Katharina Rentsch (K)

University Hospital Basel, Division of Clinical Chemistry, University of Basel, Basel, Switzerland.

Sarah Tschudin-Sutter (S)

Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.

Stefano Bassetti (S)

University Hospital Basel, Division of Internal Medicine, University of Basel, Basel, Switzerland.
University Hospital Basel, Department of Clinical Research, University of Basel, Basel, Switzerland.

Adrian Egli (A)

University Hospital Basel, Division of Clinical Bacteriology and Mycology, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. adrian.egli@usb.ch.
University Hospital Basel, Department of Clinical Research, University of Basel, Basel, Switzerland. adrian.egli@usb.ch.
Applied Microbiology Research, Department of Biomedicine, University of Basel, Basel, Switzerland. adrian.egli@usb.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH